Elon Musk's Controversial Role in the Trump Administration: A Disruptive First 100 Days
Musk's 100 days in the Trump administration saw agency dismantling, massive layoffs, and a surge of backlash, reshaping the federal government.
Musk believes he and his team have had success — and the team will continue on its mission, according to Musk, well beyond 100 days.
‘It’s Really Difficult.’: Elon Musk Reflects On Successes, Challenges Of DOGE At 100 Days
Daily Caller·14d·Mixed ReliableThis source has a mixed track record—sometimes accurate but also prone to bias, sensationalism, or incomplete reporting.RightThis outlet favors right-wing views.
Dismantling USAID is projected to cause around 176,000 excess deaths, more than half of them children, according to a Boston University tracking project.
Move fast and destroy things: 100 chaotic days of Elon Musk in the White House
The Guardian·14d·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.Leans LeftThis outlet slightly leans left.
Ultimately, savings will only reduce the deficit if Congress aggressively slashes annual funding to agencies or passes “recision” packages that claw back money that was previously appropriated.
100 Days Of DOGE: Elon Musk’s Initiative Says It Cut $200 Billion. What’s Next?
The Daily Wire·15d·Mixed ReliableThis source has a mixed track record—sometimes accurate but also prone to bias, sensationalism, or incomplete reporting.RightThis outlet favors right-wing views.
Summary
In his first 100 days as a Trump advisor, Elon Musk's "Doge" initiative has led to significant agency cuts and lay-offs, inciting profound public backlash. Musk's actions, framed as efficiency measures, have sown chaos within the government structure, targeting agencies responsible for public welfare and access to critical data. Despite touting billions in savings, the long-term impacts of his approach are yet to unfold, as lawsuits and public dissent grow against the now-disgraced leader's methods.
Perspectives
No center-leaning sources available for this story.
FAQs
No FAQs available for this story.